Screening for substance use disorders in first-episode psychosis: Implications for readmission

Schizophrenia Research

Volumn 146, Issue 1-3, 2013, Pages 125-131

  Batalla, Albert ^a,b   Garcia Rizo, Clemente ^a   Castellví, Pere ^a,c,d   Fernandez Egea, Emili ^e,f   Yücel, Murat ^g   Parellada, Eduard ^a   Kirkpatrick, Brian ^h   Martin Santos, Rocío ^a,b   Bernardo, Miguel ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g MONASH UNIVERSITY   (Australia)

^h TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Cannabis; First episode psychosis; Readmission; Screening; Substance use

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; DARTMOUTH ASSESSMENT OF LIFESTYLE INVENTORY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SUBSTANCE ABUSE; URINALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIFE STYLE; MALE; MIDDLE AGED; PATIENT READMISSION; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; ROC CURVE; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84875913527     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.02.031     Document Type: Article

References (51)

1. Addington J., Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr. Scand. 2007, 115(4):304-309.
2. Addington D.E., Beck C., Wang J., Adams B., Pryce C., Zhu H., Kang J., McKenzie E. Predictors of admission in first-episode psychosis: developing a risk adjustment model for service comparisons. Psychiatr. Serv. 2010, 61(5):483-488.
3. Alvarez-Jimenez M., Parker A.G., Hetrick S.E., McGorry P.D., Gleeson J.F. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr. Bull. 2011, 37(3):619-630.
4. Alvarez-Jimenez M., Priede A., Hetrick S.E., Bendall S., Killackey E., Parker A.G., McGorry P.D., Gleeson J.F. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr. Res. 2012, 139(1-3):116-128.
5. Baeza I., Graell M., Moreno D., Castro-Fornieles J., Parellada M., Gonzalez-Pinto A., Paya B., Soutullo C., de la Serna E., Arango C. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr. Res. 2009, 113(2-3):129-137.
6. Barnes T.R., Mutsatsa S.H., Hutton S.B., Watt H.C., Joyce E.M. Comorbid substance use and age at onset of schizophrenia. Br. J. Psychiatry 2006, 188:237-242.
7. Bennett M.E. Assessment of substance use and substance-use disorders in schizophrenia. Clin. Schizophr. Relat. Psychoses 2009, 3(1):50-63.
8. Bernardo M., Bioque M., Parellada M., Saiz R.J., Cuesta M.J., Llerena A., Sanjuan J., Castro-Fornieles J., Arango C., Cabrera B. Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs). Rev. Psiquiatr. Salud Ment. 2012, 6(1):4-16. (Nov 30.).
9. Buhler B., Hambrecht M., Loffler W., an der H.W., Hafner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse-a retrospective and prospective study of 232 population-based first illness episodes. Schizophr. Res. 2002, 54(3):243-251.
10. Cantor-Graae E., Nordstrom L.G., McNeil T.F. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr. Res. 2001, 48(1):69-82.
11. Cantwell R., Brewin J., Glazebrook C., Dalkin T., Fox R., Medley I., Harrison G. Prevalence of substance misuse in first-episode psychosis. Br. J. Psychiatry 1999, 174:150-153.
12. Caseiro O., Perez-Iglesias R., Mata I., Martinez-Garcia O., Pelayo-Teran J.M., Tabares-Seisdedos R., de la Foz Ortiz-Garcia, Vazquez-Barquero J.L., Crespo-Facorro B. Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. J. Psychiatr. Res. 2012, 46(8):1099-1105.
13. Coldham E.L., Addington J., Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr. Scand. 2002, 106(4):286-290.
14. Cougnard A., Parrot M., Grolleau S., Kalmi E., Desage A., Misdrahi D., Brun-Rousseau H., Verdoux H. Pattern of health service utilization and predictors of readmission after a first admission for psychosis: a 2-year follow-up study. Acta Psychiatr. Scand. 2006, 113(4):340-349.
15. Degenhardt L., Tennant C., Gilmour S., Schofield D., Nash L., Hall W., McKay D. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol. Med. 2007, 37(7):927-934.
16. Drake R.E., Osher F.C., Noordsy D.L., Hurlbut S.C., Teague G.B., Beaudett M.S. Diagnosis of alcohol use disorders in schizophrenia. Schizophr. Bull. 1990, 16(1):57-67.
17. European Monitoring Centre for Drugs and Drug Addiction The state of the drugs problem in Europe. EMCDDA, Lisbon Access date: 2-2-2012. Available from. http://www.emcdda.europa.eu/publications/annual-report/2011.
18. Fernandez-Egea E., Bernardo M., Donner T., Conget I., Parellada E., Justicia A., Esmatjes E., Garcia-Rizo C., Kirkpatrick B. Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br. J. Psychiatry 2009, 194(5):434-438.
19. First M., Spitzer R. SCID-I Structured Clinical Interview for the DSM-IV Axis I Disorders [Spanish] (trans. J Blanch, I Andreu) 1999, Masson edn.
20. Ford P. An evaluation of the Dartmouth Assessment of Lifestyle Inventory and the Leeds Dependence Questionnaire for use among detained psychiatric inpatients. Addiction 2003, 98(1):111-118.
21. Garcia-Rizo C., Fernandez-Egea E., Oliveira C., Justicia A., Parellada E., Bernardo M., Kirkpatrick B. Prolactin concentrations in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr. Res. 2012, 134(1):16-19.
22. Gonzalez-Pinto A., Alberich S., Barbeito S., Gutierrez M., Vega P., Ibanez B., Haidar M.K., Vieta E., Arango C. Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr. Bull. 2011, 37(3):631-639.
23. Grace R.F., Shenfield G., Tennant C. Cannabis and psychosis in acute psychiatric admissions. Drug Alcohol Rev. 2000, 19(3):287-290.
24. Grech A., van O.J., Jones P.B., Lewis S.W., Murray R.M. Cannabis use and outcome of recent onset psychosis. Eur. Psychiatry. 2005, 20(4):349-353.
25. Green A.I., Tohen M.F., Hamer R.M., Strakowski S.M., Lieberman J.A., Glick I., Clark W.S. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr. Res. 2004, 66(2-3):125-135.
26. Hides L., Dawe S., Kavanagh D.J., Young R.M. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospect. Study Br. J. Psychiatry 2006, 189:137-143.
27. Kamali M., Mctigue O., Whitty P., Gervin M., Clarke M., Browne S., Larkin C., O'callaghan E. Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms. Early Interv. Psychiatry 2009, 3(3):198-203.
28. Kavanagh D.J., McGrath J., Saunders J.B., Dore G., Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs 2002, 62(5):743-755.
29. Lambert M., Conus P., Lubman D.I., Wade D., Yuen H., Moritz S., Naber D., McGorry P.D., Schimmelmann B.G. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr. Scand. 2005, 112(2):141-148.
30. Larsen T.K., Melle I., Auestad B., Friis S., Haahr U., Johannessen J.O., Opjordsmoen S., Rund B.R., Simonsen E., Vaglum P., McGlashan T.H. Substance abuse in first-episode non-affective psychosis. Schizophr. Res. 2006, 88(1-3):55-62.
31. Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch. Gen. Psychiatry 1994, 51(4):273-279.
32. Malla A., Norman R., Bechard-Evans L., Schmitz N., Manchanda R., Cassidy C. Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychol. Med. 2008, 38(11):1585-1593.
33. Margolese H.C., Malchy L., Negrete J.C., Tempier R., Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr. Res. 2004, 67(2-3):157-166.
34. Pencer A., Addington J., Addington D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Res. 2005, 133(1):35-43.
35. Peralta V., Cuesta M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994, 53(1):31-40.
36. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264(19):2511-2518.
37. Rosenberg S.D., Drake R.E., Wolford G.L., Mueser K.T., Oxman T.E., Vidaver R.M., Carrieri K.L., Luckoor R. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. Am. J. Psychiatry 1998, 155(2):232-238.
38. Salyers M.P., Mueser K.T. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr. Res. 2001, 48(1):109-123.
39. Sorbara F., Liraud F., Assens F., Abalan F., Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur. Psychiatry 2003, 18(3):133-136.
40. Spitzer R., Williams J.B.W., Gibbon M., First M. Instruction Manual for the Structured Clinical Interview for DSM-III-R 1988, State Psychiatric Institute, Biometrics Research, New York.
41. Stirling J., Lewis S., Hopkins R., White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr. Res. 2005, 75(1):135-137.
42. Sugranyes G., Flamarique I., Parellada E., Baeza I., Goti J., Fernandez-Egea E., Bernardo M. Cannabis use and age of diagnosis of schizophrenia. Eur. Psychiatry 2009, 24(5):282-286.
43. Tiet Q.Q., Finney J.W., Moos R.H. Screening psychiatric patients for illicit drug use disorders and problems. Clin. Psychol. Rev. 2008, 28(4):578-591.
44. Turkington A., Mulholland C.C., Rushe T.M., Anderson R., McCaul R., Barrett S.L., Barr R.S., Cooper S.J. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br. J. Psychiatry 2009, 195(3):242-248.
45. Van Dorn R.A., Desmarais S.L., Scott Y.M., Sellers B.G., Swartz M.S. Assessing illicit drug use among adults with schizophrenia. Psychiatry Res. 2012, (Dec 30. http://dx.doi.org/10.1016/j.psychres.2012.05.028).
46. Van Mastrigt S., Addington J., Addington D. Substance misuse at presentation to an early psychosis program. Soc. Psychiatry Psychiatr. Epidemiol. 2004, 39(1):69-72.
47. Verstraete A.G. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit. 2004, 26(2):200-205.
48. Wade D., Harrigan S., Edwards J., Burgess P.M., Whelan G., McGorry P.D. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br. J. Psychiatry 2006, 189:229-234.
49. Wade D., Harrigan S., McGorry P.D., Burgess P.M., Whelan G. Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis. J. Clin. Psychiatry 2007, 68(5):767-774.
50. Wisdom J.P., Manuel J.I., Drake R.E. Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment. Psychiatr. Serv. 2011, 62(9):1007-1012.
51. Zammit S., Moore T.H., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br. J. Psychiatry 2008, 193(5):357-363.